- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5685 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone having an oxo group in position 17, e.g. androsterone
Patent holdings for IPC class A61K 31/5685
Total number of patents in this class: 268
10-year publication summary
|
14
|
21
|
27
|
21
|
29
|
28
|
20
|
21
|
21
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10623 |
11 |
| Endorecherche, Inc. | 23 |
10 |
| Allergan, Inc. | 2314 |
8 |
| Duke University | 3107 |
8 |
| The Johns Hopkins University | 5751 |
6 |
| Havah Therapeutics Pty Ltd | 20 |
6 |
| Celgene Quanticel Research, Inc. | 162 |
5 |
| Curadis GmbH | 6 |
5 |
| Eli Lilly and Company | 3925 |
5 |
| Windtree Therapeutics, Inc. | 35 |
5 |
| Société des Produits Nestlé S.A. | 9886 |
4 |
| Board of Regents, The University of Texas System | 5938 |
4 |
| Antares Pharma, Inc. | 173 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2991 |
4 |
| Lucolas-m.d. Ltd. | 5 |
4 |
| Universidad Pablo de Olavide | 44 |
4 |
| Seismic Pharmaceuticals | 6 |
4 |
| Pfizer Inc. | 3401 |
3 |
| Assistance Publique - Hopitaux de Paris | 1031 |
3 |
| io Therapeutics, Inc. | 120 |
3 |
| Other owners | 162 |